Xponance’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Xponance’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,130	Closed	-$466K	–	1048
2020 Q2	$466K	Sell	11,130 -5,726	-34%	-$226K	0.01%	637
2020 Q1	$534K	Hold	16,856	–	–	0.44%	52
2019 Q4	$713K	Hold	16,856	–	–	0.44%	28
2019 Q3	$531K	Buy	16,856 +1,265	+8%	+$44.5K	0.29%	43
2019 Q2	$563K	Hold	15,591	–	–	0.2%	45
2019 Q1	$564K	Buy	15,591 +2,650	+20%	+$88.5K	0.2%	49
2018 Q4	$364K	Hold	12,941	–	–	0.14%	53
2018 Q3	$509K	Buy	12,941 +635	+5%	+$24.1K	0.17%	57
2018 Q2	$458K	Buy	12,306 +3,810	+45%	+$138K	0.21%	50
2018 Q1	$290K	Buy	8,496 +4,912	+137%	+$172K	0.12%	53
2017 Q4	$131K	Buy	+3,584	New	+$112K	0.08%	39

Other funds holding SBIO

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Xponance's SBIO Position: Q3 2020 in Review

Xponance sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2020, closing a stake of 11,130 shares — an estimated $466K sold.

Xponance first reported a position in SBIO in Q4 2017 and held it in 11 quarters. The position peaked at $713K in Q4 2019. 52 funds tracked by Wall St. Rank hold SBIO as of Q3 2020.

Xponance reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2020 after selling out during the quarter.
Xponance sold 11,130 ALPS Medical Breakthroughs ETF shares in Q3 2020, an estimated $466K.
Xponance first reported a position in ALPS Medical Breakthroughs ETF in Q4 2017 and held it in 11 quarters.
Xponance's ALPS Medical Breakthroughs ETF position peaked at $713K in Q4 2019.
52 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2020.

Based on Xponance's 13F filing for Q3 2020, filed 26 Oct 2020.